Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β

Veenu Tripathi1, Katherine M Sixt1, Shaojian Gao2

  • 1Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Molecular Cell
|October 18, 2016
PubMed

Insights

Transforming growth factor-beta (TGF-β) switches from inhibiting to promoting cancer by altering CD44 splicing via SMAD3 and PCBP1 interaction. This mechanism is crucial for tumor progression and metastasis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Transforming growth factor-beta (TGF-β) paradoxically promotes tumor progression in advanced cancers, despite its inhibitory role in early stages.
  • The mechanisms by which TGF-β cooperates with receptor tyrosine kinase pathways to drive tumor growth remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying TGF-β's switch from a tumor suppressor to a tumor promoter.
  • To investigate the role of alternative splicing in TGF-β-mediated cancer progression.

Main Methods:

  • Investigated the interaction between SMAD3 and PCBP1 in response to TGF-β and EGF signaling.
  • Analyzed the alternative splicing of CD44 pre-mRNA in nuclear speckles.
  • Utilized cell-based assays to assess the functional impact of SMAD3-mediated splicing on cancer progression.

Main Results:

  • TGF-β directly regulates CD44 alternative splicing through a phosphorylated SMAD3-mediated interaction with PCBP1.
  • TGF-β and EGF signaling induce SMAD3 and PCBP1 to colocalize in nuclear speckles, where they interact with CD44 pre-mRNA.
  • This interaction inhibits spliceosome assembly, favoring the mesenchymal CD44s isoform over the epithelial CD44E isoform.
  • SMAD3-mediated alternative splicing is essential for TGF-β's tumor-promoting functions and influences epithelial-to-mesenchymal transition and metastasis.

Conclusions:

  • TGF-β promotes cancer progression by directly altering CD44 alternative splicing via the SMAD3-PCBP1 complex.
  • This splicing switch is a critical mechanism for TGF-β to promote epithelial-to-mesenchymal transition and metastasis.
  • Targeting this pathway could offer novel therapeutic strategies for advanced cancers.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.8K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.1K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.4K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.3K